| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,486,900 | 1,126,300 | 1,295,900 | 1,386,100 | | Cost of Revenue | 1,244,600 | 955,600 | 1,154,300 | 1,234,700 | | | Gross Profit | 242,300 | 170,700 | 141,600 | 151,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 106,700 | 107,900 | 103,200 | 118,000 | | Non Recurring | 2,000 |
-
| 1,197,800 |
-
| | Others | 15,500 | 14,800 | 15,800 | 16,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 118,100 | 48,000 | (1,175,200) | 17,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,500 | 4,100 | (1,900) | 4,600 | | Earnings Before Interest And Taxes | 124,600 | 52,100 | (1,177,100) | 21,700 | | Interest Expense | 63,400 | 62,700 | 41,900 | 44,800 | | Income Before Tax | 61,200 | (10,600) | (1,219,000) | (23,100) | | Income Tax Expense | 8,000 | 900 | (26,800) | (1,800) | | Minority Interest | 200 | 300 | 200 | 200 | | | | Net Income From Continuing Ops | 52,400 | (12,100) | (1,192,000) | (20,600) | | | Non-recurring Events | | Discontinued Operations | 87,900 | (14,400) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 140,300 | (26,500) | (1,192,000) | (20,600) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $140,300 | ($26,500) | ($1,192,000) | ($20,600) |
|
0.08% Nasdaq 
0.16%
Income Statement
